California Public Employees Retirement System Adc Therapeutics Sa Transaction History

California Public Employees Retirement System

  • $147 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$20.38 - $27.04 $1.51 Million - $2 Million
-73,925 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$22.75 - $34.05 $359,563 - $538,160
-15,805 Reduced 17.61%
73,925 $1.81 Million
Q4 2020

Feb 02, 2021
BUY
$25.26 - $38.02 $1.56 Million - $2.35 Million
61,700 Added 220.12%
89,730 $2.87 Million
Q3 2020

Nov 05, 2020
BUY
$32.87 - $51.05 $921,346 - $1.43 Million
28,030 New
28,030 $925,000

Others Institutions Holding ADCT

# of Institutions
85
Shares Held
53.5M
Call Options Held
28K
Put Options Held
60.4K
View Full List

About ADC Therapeutics SA

ADCT Quotes by TradingView
  • Ticker ADCT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,645,296
  • Market Cap $124M
  • Description
  • ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates (ADC) for patients suffering from hematological malignancies and solid tumors. Its flagship product ZYNLONTA that is in Phase II clinical trial for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma;...
More about ADCT
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email